← Leaderboards
Kathleen C Brown
Children'S Research Institute
$35,022
Attributed
$35,022
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $15K · FY2006–08$20K$15K$10K$5K$0
'06
'07
'08
Funding mix
By agency
NIH$35,022 · 4
By mechanism
M01$35,022 · 4
Top collaborators
No co-investigators on record.
Most similar at Children'S Research Institute
Same institution · by research overlap
- Lawrence D'angelo$13,627,486
- Mark L Batshaw$21,890,139
- Catherine Mary Bollard$14,999,215
- Adeline Lucie Vanderver$19,932,242
- Andrea Lynne Gropman$6,318,642
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodCohortComputer Retrieval Of Information On Scientific Projects DatabaseDoseDrug KineticsEnrollmentExclusion CriteriaFundingGrantHepaticInstitutionKidneyLorazepamPurposeResearch PersonnelResourcesSample SizeSourceStatus EpilepticusUnited States National Institutes Of Health
Grant awards (4)
USE OF LORAZEPAM FOR PEDIATRIC STATUS EPILEPTICUS (COHORT 2)$13,692
M01 · FY2008 · RR · contact PI
USE OF LORAZEPAM FOR PEDIATRIC STATUS EPILEPTICUS (COHORT 2)$6,357
M01 · FY2007 · RR · contact PI
THE EFFECTIVENESS OF ORAL DEXAMETHASONE FOR ACUTE BRONCHIOLITIS: A MULTICENTER R$11,875
M01 · FY2006 · RR · contact PI
USE OF LORAZEPAM FOR PEDIATRIC STATUS EPILEPTICUS (COHORT 2)$3,098
M01 · FY2006 · RR · contact PI